How should I manage an elevated total cholesterol (231 mg/dL)?

Management of Total Cholesterol 231 mg/dL

You need a complete fasting lipid panel (LDL-C, HDL-C, triglycerides) to determine appropriate management, as total cholesterol alone is insufficient for treatment decisions—LDL-C is the primary target for therapy. 1, 2

Initial Assessment Algorithm

Your immediate next steps depend on obtaining the full lipid profile:

1. Order Fasting Lipid Panel

• Must include: LDL-C, HDL-C, triglycerides, calculated non-HDL-C
• Obtain within 24 hours if you have known cardiovascular disease 3, 1
• For primary prevention, can be done at routine visit

2. Assess Cardiovascular Risk Category

Once you have LDL-C, classify the patient into risk categories:

Very High Risk:

• Known atherosclerotic cardiovascular disease (prior MI, stroke, PAD, ACS)
• Diabetes with target organ damage
• Multiple major risk factors

High Risk:

• Diabetes without complications
• 10-year ASCVD risk ≥7.5%
• Multiple cardiovascular risk factors

Moderate Risk:

• 10-year ASCVD risk <7.5%
• 1-2 risk factors present

Treatment Targets Based on LDL-C and Risk

If LDL-C ≥100 mg/dL:

For patients with known cardiovascular disease or very high risk:

• Primary goal: LDL-C <100 mg/dL 1, 2
• Optimal goal: LDL-C <70 mg/dL is reasonable and preferred 1, 4
• Initiate statin therapy immediately, regardless of baseline LDL-C 1
• Aim for 30-40% LDL-C reduction minimum 5

For primary prevention (no known disease):

• If LDL-C ≥190 mg/dL: Start statin therapy 6
• If LDL-C 160-189 mg/dL with ≥2 risk factors: Start statin after 12 weeks of lifestyle modification 7
• If LDL-C 130-159 mg/dL with ≥2 risk factors and 10-year risk ≥10%: Start statin after lifestyle modification trial 7

If LDL-C 70-100 mg/dL:

For very high-risk patients:

• It is reasonable to treat to LDL-C <70 mg/dL 1, 3
• Consider statin therapy even in this range for secondary prevention

For primary prevention:

• Intensive lifestyle modification
• Consider statin if multiple risk factors present

Immediate Lifestyle Interventions (Start for ALL Patients)

Initiate these dietary changes immediately while awaiting full lipid panel 3, 2, 5:

Dietary modifications:

• Saturated fat <7% of total calories
• Cholesterol <200 mg/day
• Trans fats <1% of total calories
• Add plant stanols/sterols 2 g/day (reasonable to further lower LDL-C) 3
• Add viscous fiber >10 g/day 1, 4

Physical activity:

• 30-60 minutes moderate-intensity aerobic activity most days (minimum 5 days/week) 3, 2
• Resistance training 2 days/week may be reasonable 3

Weight management:

• Target BMI 18.5-24.9 kg/m² 3
• Waist circumference <40 inches (men), <35 inches (women) 7

Medication Selection When Indicated

First-line therapy: Statin 1, 4

• Most effective for LDL-C reduction
• Proven mortality benefit in cardiovascular disease
• Dose intensity based on needed LDL-C reduction

If statin alone insufficient:

• Add ezetimibe (standard dose statin + ezetimibe) 5
• Consider bile acid sequestrant 7
• Consider niacin (after LDL-lowering therapy) 1, 4

For very high-risk patients not at goal:

• Consider PCSK9 inhibitors for LDL-C <70 mg/dL target 6

Critical Pitfalls to Avoid

1. Do NOT treat based on total cholesterol alone—this is outdated practice. LDL-C drives treatment decisions 1, 2

2. Do NOT delay statin therapy in patients with known cardiovascular disease—initiate before hospital discharge if presenting with acute event 3, 1

3. Do NOT use total cholesterol of 200 mg/dL as a treatment threshold—this is a screening value only, not a treatment target 7

4. Rule out secondary causes if LDL-C is elevated: Check TSH, liver function tests, urinalysis, fasting glucose 7

5. For Asian patients on rosuvastatin: Start with 5 mg dose (lower than standard 10 mg) due to higher drug levels 6

Special Considerations for Triglycerides

If triglycerides are elevated when you get the full panel:

• Triglycerides 200-499 mg/dL: Non-HDL-C goal <130 mg/dL; consider more intense LDL-lowering or add niacin/fibrate after LDL goal achieved 1, 4
• Triglycerides ≥500 mg/dL: Fibrate or niacin therapy indicated to prevent pancreatitis; treat triglycerides before focusing on LDL-C 3, 1